These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10698 related articles for article (PubMed ID: 1580557)
1. Expression of alpha-melanocyte stimulating hormone and the invasive ability of the B16 murine melanoma. Zubair A; Lakshmi MS; Sherbet GV Anticancer Res; 1992; 12(2):399-402. PubMed ID: 1580557 [TBL] [Abstract][Full Text] [Related]
2. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells. Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027 [TBL] [Abstract][Full Text] [Related]
3. Expression of the transmembrane glycoprotein CD44 and metastasis associated 18A2/MTS1 gene in B16 murine melanoma cells. Lakshmi MS; Parker C; Sherbet GV Anticancer Res; 1997; 17(5A):3451-5. PubMed ID: 9413186 [TBL] [Abstract][Full Text] [Related]
4. Gene transfer of pro-opiomelanocortin prohormone suppressed the growth and metastasis of melanoma: involvement of alpha-melanocyte-stimulating hormone-mediated inhibition of the nuclear factor kappaB/cyclooxygenase-2 pathway. Liu GS; Liu LF; Lin CJ; Tseng JC; Chuang MJ; Lam HC; Lee JK; Yang LC; Chan JH; Howng SL; Tai MH Mol Pharmacol; 2006 Feb; 69(2):440-51. PubMed ID: 16269535 [TBL] [Abstract][Full Text] [Related]
5. Biological activity, binding, and metabolic fate of Ac-[Nle4, D-Phe7]alpha-MSH4-11NH2 with the F1 variant of B16 melanoma cells. Panasci LC; McQuillan A; Kaufman M J Cell Physiol; 1987 Jul; 132(1):97-103. PubMed ID: 3110178 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models. Miao Y; Owen NK; Fisher DR; Hoffman TJ; Quinn TP J Nucl Med; 2005 Jan; 46(1):121-9. PubMed ID: 15632042 [TBL] [Abstract][Full Text] [Related]
7. Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9. Bianchini F; D'Alessio S; Fibbi G; Del Rosso M; Calorini L Oncol Rep; 2006 Mar; 15(3):709-14. PubMed ID: 16465434 [TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting properties of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model. Miao Y; Hoffman TJ; Quinn TP Nucl Med Biol; 2005 Jul; 32(5):485-93. PubMed ID: 15982579 [TBL] [Abstract][Full Text] [Related]
9. Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Takaoka A; Adachi M; Okuda H; Sato S; Yawata A; Hinoda Y; Takayama S; Reed JC; Imai K Oncogene; 1997 Jun; 14(24):2971-7. PubMed ID: 9205104 [TBL] [Abstract][Full Text] [Related]
10. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice. Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential. Sawada M; Moriya S; Shineha R; Satomi S; Miyagi T Acta Biochim Pol; 1998; 45(2):343-9. PubMed ID: 9821865 [TBL] [Abstract][Full Text] [Related]
12. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma]. Zheng HQ; Liu DY Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989 [TBL] [Abstract][Full Text] [Related]
13. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Ishiguro T; Nakajima M; Naito M; Muto T; Tsuruo T Cancer Res; 1996 Feb; 56(4):875-9. PubMed ID: 8631027 [TBL] [Abstract][Full Text] [Related]
14. Radiolabeled alpha-melanocyte-stimulating hormone analogs for receptor-mediated targeting of melanoma: from tritium to indium. Eberle AN; Froidevaux S J Mol Recognit; 2003; 16(5):248-54. PubMed ID: 14523936 [TBL] [Abstract][Full Text] [Related]
15. Induction of autocrine factor inhibiting cell motility from murine B16-BL6 melanoma cells by alpha-melanocyte stimulating hormone. Murata J; Ayukawa K; Ogasawara M; Watanabe H; Saiki I Int J Cancer; 1999 Mar; 80(6):889-95. PubMed ID: 10074923 [TBL] [Abstract][Full Text] [Related]